Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

AHS HENRYETTA HOSPITAL LLC

NPI: 1720053556 · HENRYETTA, OK 74437 · General Acute Care Hospital · NPI assigned 02/23/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official PETROVICH, STEPHEN controls 20+ related entities in our dataset. Read more

$4.27M
Total Medicaid Paid
47,150
Total Claims
45,104
Beneficiaries
53
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPETROVICH, STEPHEN (SVP)
NPI Enumeration Date02/23/2006

Related Entities

Other providers sharing the same authorized official: PETROVICH, STEPHEN

ProviderCityStateTotal Paid
LOVELACE HEALTH SYSTEM, LLC ALBUQUERQUE NM $57.71M
LOVELACE HEALTH SYSTEM LLC ALBUQUERQUE NM $45.27M
SOUTHWEST MEDICAL ASSOCIATES, LLC ALBUQUERQUE NM $41.40M
LOVELACE HEALTH SYSTEM, LLC ALBUQUERQUE NM $31.24M
LOVELACE HEALTH SYSTEM LLC ROSWELL NM $20.13M
JACKSONVILLE HOSPITAL LLC JACKSONVILLE TX $9.41M
HENDERSON HOSPITAL, LLC HENDERSON TX $8.52M
ATHENS HOSPITAL, LLC ATHENS TX $8.32M
ETMC PHYSICIAN GROUP INC. TYLER TX $8.03M
TYLER REGIONAL HOSPITAL LLC TYLER TX $7.94M
LOVELACE UNM REHABILITATION HOSPITAL LLC ALBUQUERQUE NM $6.30M
POCATELLO HOSPITAL LLC POCATELLO ID $6.11M
JACKSONVILLE HOSPITAL LLC JACKSONVILLE TX $5.93M
AHS PRYOR HOSPITAL, LLC PRYOR OK $5.61M
BSA HOSPITAL LLC AMARILLO TX $4.96M
PITTSBURG HOSPITAL LLC PITTSBURG TX $4.83M
AHS CLAREMORE REGIONAL HOSPITAL, LLC. CLAREMORE OK $4.81M
PITTSBURG HOSPITAL LLC PITTSBURG TX $3.98M
TOPEKA HOSPITAL, LLC TOPEKA KS $3.94M
AHS PRYOR HOSPITAL, LLC PRYOR OK $3.76M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 3,255 $298K
2019 4,779 $454K
2020 4,006 $391K
2021 7,867 $689K
2022 14,476 $1.17M
2023 9,123 $824K
2024 3,644 $443K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 6,462 6,342 $1.46M
99283 Emergency department visit for the evaluation and management, moderate severity 7,553 7,465 $1.25M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 3,273 3,204 $961K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1,414 1,388 $173K
87428 2,129 2,106 $81K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,000 978 $66K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,782 2,753 $44K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 6,051 5,000 $41K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 855 775 $38K
80053 Comprehensive metabolic panel 2,192 2,125 $20K
74177 Computed tomography, abdomen and pelvis; with contrast material 112 111 $19K
36415 Collection of venous blood by venipuncture 3,807 3,566 $18K
96375 Therapeutic injection; each additional sequential IV push 406 392 $17K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 507 484 $15K
87081 1,785 1,766 $11K
71045 Radiologic examination, chest; single view 817 799 $10K
71046 Radiologic examination, chest; 2 views 533 514 $10K
99282 Emergency department visit for the evaluation and management, low to moderate severity 76 76 $9K
81001 2,349 2,310 $7K
87400 243 235 $6K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 54 24 $4K
96361 Intravenous infusion, hydration; each additional hour 114 109 $4K
87807 338 333 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 24 24 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor 51 51 $2K
70450 Computed tomography, head or brain; without contrast material 41 41 $2K
80305 139 138 $2K
84703 188 186 $1K
80048 Basic metabolic panel (calcium, ionized) 120 118 $896.07
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 137 137 $705.73
80306 40 38 $594.75
83690 66 66 $386.91
83655 36 36 $340.33
82140 24 24 $311.04
80061 Lipid panel 25 24 $309.47
84484 16 15 $246.81
84443 Thyroid stimulating hormone (TSH) 14 14 $209.16
80143 12 12 $198.96
83605 14 13 $186.42
87086 Culture, bacterial; quantitative colony count, urine 25 25 $175.50
82607 12 12 $160.92
83735 24 24 $143.04
85014 48 48 $99.17
85018 48 48 $99.17
82150 12 12 $69.12
85730 12 12 $64.20
84100 12 12 $50.64
85610 12 12 $45.84
J7030 Infusion, normal saline solution , 1000 cc 716 686 $5.81
J7050 Infusion, normal saline solution, 250 cc 263 257 $5.06
J2405 Injection, ondansetron hydrochloride, per 1 mg 12 12 $3.84
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 127 125 $2.34
J0696 Injection, ceftriaxone sodium, per 250 mg 28 27 $0.00